UNITED STATES BARIATRIC SURGERY MARKET FORECAST 2024-2032

Among the various types of bariatric surgeries, gastric bypass stands out as one of the most commonly performed procedures in the United States. Many surgeons favor gastric bypass due to its relatively lower complication rates compared to other weight-loss surgeries.

Additionally, sleeve gastrectomy has emerged as the predominant method of weight-loss surgery in the United States, surpassing laparoscopic gastric bypass, which had long held the title as the most common procedure. This shift in preference has been observed by researchers at Cleveland Clinic.

The United States bariatric surgery market segmentation includes device, end-user, and procedure. The procedure segment includes adjustable gastric band, gastric bypass, biliopancreatic diversion with duodenal switch, and gastric sleeve surgery.

Gastric sleeve surgery, also known as sleeve gastrectomy, has emerged as a significant player in the bariatric surgery market. This minimally invasive procedure involves the removal of a large portion of the stomach, leaving behind a smaller ‘sleeve’ or tube-shaped stomach.

As one of the most popular and effective weight-loss surgeries, gastric sleeve surgery has garnered widespread attention for its ability to produce substantial and sustainable weight-loss results. It works by reducing the stomach’s capacity, leading to a decreased appetite and earlier feelings of fullness, which in turn facilitates weight loss.

In recent years, gastric sleeve surgery has witnessed a notable rise in demand, driven by several factors. Firstly, its efficacy in achieving significant weight loss and improving obesity-related health conditions such as type 2 diabetes, hypertension, and sleep apnea has contributed to its popularity among patients and healthcare providers alike. Moreover, the minimally invasive nature of the procedure and shorter recovery times compared to traditional open surgeries have made it an attractive option for many individuals seeking long-term weight management solutions.

Furthermore, advancements in surgical techniques and technology have further enhanced the safety and efficacy of gastric sleeve surgery, making it a preferred choice for both patients and surgeons. With increasing awareness of the health risks associated with obesity and the growing emphasis on overall wellness, gastric sleeve surgery is expected to continue playing a pivotal role in the bariatric surgery market, offering hope and improved quality of life to individuals struggling with obesity.

Some of the eminent companies in the United States bariatric surgery market include USGI Medical Inc, Olympus Corporation, Johnson & Johnson, etc.

Johnson & Johnson (J&J) is engaged in the research, development, manufacturing, and sale of pharmaceutical products and medical devices. Operating through its subsidiary companies, J&J offers a wide range of pharmaceuticals targeting immune disorders, cancer, neurological disorders, infectious diseases, cardiovascular ailments, and metabolic disorders. Additionally, the company provides medical devices catering to cardiovascular, orthopedic, neurovascular care, general surgery, and vision care fields. 

J&J distributes its pharmaceutical and medical products to various channels, including retailers, wholesalers, healthcare professionals, and hospitals. Its product offerings span across regions including the US, Europe, Asia-Pacific, Africa, Western Hemisphere (excluding the US), and Latin America. Headquartered in New Brunswick, New Jersey, USA, J&J maintains its global presence as a leader in the healthcare industry.